UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer: Recnt treatmnt dvlpmnts

Описание к видео UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer: Recnt treatmnt dvlpmnts

In this recording we will address the following questions:

-Is PSMA-PET scan the preferred imaging modality in mHSPC or are bone and CT scans sufficient?
-What is the best treatment for men with mHSPC?
-Is it the combination treatment of androgen deprivation therapy (ADT) plus docetaxel or an androgen receptor signaling inhibitor (ARSi) or triplet therapy?
-Are any of these combination treatments for high-volume disease only?
What is the indication for adding radiotherapy?
-Is there a difference between treatment for de novo disease or recurrent disease after treatment of the primary tumour?

Комментарии

Информация по комментариям в разработке

Похожие видео